PubMed:22186986 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/22186986","sourcedb":"PubMed","sourceid":"22186986","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/22186986","text":"Safety of negative-pressure wound therapy over ocular structures.\nThis is a report of the use, efficacy, and theoretic safety of negative-pressure wound therapy over ocular structures as a part of surgical treatment for necrotizing fasciitis. We treated a 65-year-old man with facial necrotizing fasciitis requiring serial debridement and closure of extensive periorbital and nasal wounds with skin grafts. Negative-pressure wound therapy was first used as a bridge to allow temporary closure and to encourage granulation tissue development. It was then used as a bolster dressing to stabilize skin grafts in the complex wound, not amenable to tie-over dressings. Excellent functional and cosmetic reconstruction of the periorbital and nasal regions was achieved. After treatment, the patient's corrected vision was 20/20. To our knowledge, the use of negative-pressure wound therapy directly over ocular structures has not been previously documented. In this case, it was safely used over the eyes with no sequelae to the patient's vision.","tracks":[{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":232,"end":241},"obj":"HP_0100537"},{"id":"T2","span":{"begin":296,"end":305},"obj":"HP_0100537"}],"attributes":[{"subj":"T1","pred":"source","obj":"PubmedHPO"},{"subj":"T2","pred":"source","obj":"PubmedHPO"}]},{"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":232,"end":241},"obj":"HP:0100537"},{"id":"AB2","span":{"begin":296,"end":305},"obj":"HP:0100537"}],"attributes":[{"subj":"AB1","pred":"source","obj":"PubCasesHPO"},{"subj":"AB2","pred":"source","obj":"PubCasesHPO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PubmedHPO","color":"#93cbec","default":true},{"id":"PubCasesHPO","color":"#e5ec93"}]}]}}